UA103885C2 - Immunogenic streptococcus proteins - Google Patents

Immunogenic streptococcus proteins

Info

Publication number
UA103885C2
UA103885C2 UAA201002376A UAA201002376A UA103885C2 UA 103885 C2 UA103885 C2 UA 103885C2 UA A201002376 A UAA201002376 A UA A201002376A UA A201002376 A UAA201002376 A UA A201002376A UA 103885 C2 UA103885 C2 UA 103885C2
Authority
UA
Ukraine
Prior art keywords
proteins
immunogenic
streptococcus
eliciting
immune response
Prior art date
Application number
UAA201002376A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Хильда Элизабет СМИТ
Original Assignee
Берингер Ингельхайм Ветмедика Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Ветмедика Гмбх filed Critical Берингер Ингельхайм Ветмедика Гмбх
Publication of UA103885C2 publication Critical patent/UA103885C2/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
UAA201002376A 2007-08-06 2008-08-05 Immunogenic streptococcus proteins UA103885C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113844A EP2023143A1 (en) 2007-08-06 2007-08-06 Immunogenic streptococcus proteins
PCT/NL2008/050537 WO2009020391A1 (en) 2007-08-06 2008-08-05 Immunogenic streptococcus proteins

Publications (1)

Publication Number Publication Date
UA103885C2 true UA103885C2 (en) 2013-12-10

Family

ID=38890252

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201002376A UA103885C2 (en) 2007-08-06 2008-08-05 Immunogenic streptococcus proteins

Country Status (19)

Country Link
US (1) US20100297183A1 (enExample)
EP (3) EP2023143A1 (enExample)
JP (2) JP5462164B2 (enExample)
KR (1) KR20100063706A (enExample)
CN (1) CN101821627A (enExample)
AR (1) AR067830A1 (enExample)
AU (1) AU2008284491A1 (enExample)
BR (1) BRPI0815604A2 (enExample)
CA (1) CA2695721A1 (enExample)
CL (1) CL2008002320A1 (enExample)
CO (1) CO6270172A2 (enExample)
DK (1) DK2183597T3 (enExample)
ES (1) ES2432407T3 (enExample)
MX (1) MX2010001482A (enExample)
RU (1) RU2518315C2 (enExample)
TW (1) TW200911999A (enExample)
UA (1) UA103885C2 (enExample)
WO (1) WO2009020391A1 (enExample)
ZA (1) ZA201000806B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000005378A2 (en) 1998-07-22 2000-02-03 Id-Lelystad Instituut Voor Dierhouderij En Diergezondheid B.V. Streptococcus suis vaccines and diagnostic tests
WO2002061070A2 (en) 2001-02-02 2002-08-08 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes, involved in the virulence of streptococcus suis
GB0818231D0 (en) * 2008-10-06 2008-11-12 Univ Nottingham Composition
KR20200039025A (ko) * 2013-09-19 2020-04-14 조에티스 서비시즈 엘엘씨 유성 아쥬반트
JP2018504381A (ja) * 2014-12-22 2018-02-15 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 細胞透過性ペプチド
CA3001433A1 (en) 2015-10-21 2017-04-27 Minervax Aps Immunogenic fusion protein
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
RU2685957C2 (ru) * 2016-12-28 2019-04-23 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Химерный рекомбинантный белок, обладающий протективными свойствами в отношении Streptococcus pyogenes
JP2024500837A (ja) * 2020-12-23 2024-01-10 チャン ザッカーバーグ バイオハブ, インコーポレイテッド 抗原特異的t細胞を惹起するように操作された細菌
CN112773891B (zh) * 2021-02-01 2022-03-25 北部湾大学 卵形鲳鲹源无乳链球菌dna疫苗及其制备方法和应用
CN119219752B (zh) * 2024-09-12 2026-04-03 华中农业大学 一种猪链球菌抗原蛋白及其筛选方法及其应用
CN119780429B (zh) * 2024-12-27 2025-12-26 华派生物技术(集团)股份有限公司 一种提高猪圆环病毒2型Cap蛋白抗原琼扩检测灵敏度的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283507A (en) 1990-12-20 1994-02-01 General Electric Company Regenerative braking protection for an electrically-propelled traction vehicle
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
IT1251435B (it) 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
AU2638595A (en) * 1994-05-16 1995-12-05 Uab Research Foundation, The (streptococcus pneumoniae) capsular polysaccharide genes and flanking regions
US5681570A (en) * 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
EP0750042A1 (fr) * 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Bactéries lactiques produisant des exopolysaccharides
DE69723434T2 (de) 1996-04-26 2004-05-19 Rijksuniversiteit Te Leiden Verfahren zur selektion und produktion von t-zell-peptide epitope und vakzine mit diese epitope
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
WO2000005378A2 (en) * 1998-07-22 2000-02-03 Id-Lelystad Instituut Voor Dierhouderij En Diergezondheid B.V. Streptococcus suis vaccines and diagnostic tests
CA2355364C (en) * 1998-12-21 2014-03-18 Medimmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
JP5249482B2 (ja) * 1999-06-16 2013-07-31 ボストン・バイオメデイカル・リサーチ・インステイテユート インビボのβ−アミロイドレベルの免疫学的制御
ES2316450T3 (es) * 2000-06-12 2009-04-16 University Of Saskatchewan Proteina gapc quimerica de streptococcus y su uso en vacunacion y diagnostico.
EP1205552A1 (en) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
WO2002061070A2 (en) * 2001-02-02 2002-08-08 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes, involved in the virulence of streptococcus suis
MXPA05005539A (es) * 2002-11-26 2006-02-10 Univ Tennessee Res Foundation Molecula de adhesion streptococcus uberis.
EP1590368B1 (en) * 2003-01-27 2014-02-26 Københavns Universitet Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
EP1629005A2 (en) * 2003-05-30 2006-03-01 Intercell AG Enterococcus antigens
WO2006048763A1 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
EP2029173B1 (en) * 2006-06-26 2016-07-20 MacroGenics, Inc. Fc riib-specific antibodies and methods of use thereof

Also Published As

Publication number Publication date
CL2008002320A1 (es) 2009-09-25
AU2008284491A1 (en) 2009-02-12
ZA201000806B (en) 2010-10-27
EP2660604A3 (en) 2014-02-12
RU2010107878A (ru) 2011-09-20
CO6270172A2 (es) 2011-04-20
EP2183597B1 (en) 2013-07-24
CA2695721A1 (en) 2009-02-12
AR067830A1 (es) 2009-10-21
RU2518315C2 (ru) 2014-06-10
JP2010535500A (ja) 2010-11-25
MX2010001482A (es) 2010-03-01
CN101821627A (zh) 2010-09-01
EP2023143A1 (en) 2009-02-11
ES2432407T3 (es) 2013-12-03
JP2014095721A (ja) 2014-05-22
DK2183597T3 (da) 2013-10-14
KR20100063706A (ko) 2010-06-11
TW200911999A (en) 2009-03-16
WO2009020391A1 (en) 2009-02-12
EP2660604A2 (en) 2013-11-06
US20100297183A1 (en) 2010-11-25
EP2183597A1 (en) 2010-05-12
BRPI0815604A2 (pt) 2015-03-03
JP5462164B2 (ja) 2014-04-02

Similar Documents

Publication Publication Date Title
MX2010001482A (es) Proteinas de streptococcus inmunogenicas.
BRPI0707154B8 (pt) composição de vacina
EP1219711A3 (en) Lawsonia intracellularis vaccine
WO2008127179A8 (en) Fusion protein vaccine
EP1917033A4 (en) VIRUS LIKE PARTICLES AS PARAMYXOVIRUS VACCINES
WO2007106476A3 (en) Compositions and methods for enhancing the immunogenicity of antigens
ATE522541T1 (de) Bakterielle adhäsine konformere
PH12013500204A1 (en) Polypeptides for treating and/or limiting influenza infection
WO2008137881A3 (en) Ehrlichia ewingii proteins, nucleic acids, and methods of their use
WO2005070958A3 (en) Lawsonia intracellularis subunit vaccines
WO2009009039A3 (en) Compositions containing full-length l1r nucleic acid and endoplasmic reticulum targeting sequence
WO2007041216A3 (en) Plasmodium liver stage antigens
EP2251035A3 (en) New virulence factors of Streptococcus pneumoniae
WO2005026200A3 (en) Lawsonia intracellularis subunit vaccine
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
BRPI1014505A8 (pt) Proteína de fusão de múltiplos epítopos, método para produzir uma composição, polinucleotídeo, vetor recombinante, célula hospedeira, método para produzir uma proteína de fusão de múltiplos epítopos, kit de teste imunodiagnóstico, composição, e, uso de uma proteína de fusão de múltiplos epítopos
WO2013138259A3 (en) Polypeptides for treating and/or limiting influenza infection
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
WO2010046778A3 (en) Novel shigella frotein antigens and methods
WO2008002548A3 (en) Novel human acidic mammalian chitinase and use thereof
WO2006113782A3 (en) Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
WO2005026199A3 (en) Piroplasmid vaccine
PL1716169T3 (pl) Podjednostkowe szczepionki przeciwko Ornithobacterium rhinotracheale
WO2010041938A3 (en) New virulence factors of streptococcus pneumoniae
Ruan et al. Identification on the immunogenic activity of recombinant rLTB/CTB-LipL41/1 to Leptospira interrogans and detection of lipL41 gene with its production